Back to search

Article

Four Decades of Molecular Innovation in Chronic Myeloid Leukemia: From Antisense Targeting to Treatment-Free Remission

2026-04-09

Abstract excerpt

<h4>Background: </h4> Chronic myeloid leukemia (CML) is a paradigm of targeted therapy, driven by the BCR::ABL1 fusion kinase. Over the past four decades, therapeutic strategies have evolved from early molecular targeting approaches and interferon-α to tyrosine kinase inhibitors (TKIs), dramatically improving survival and transforming CML into a largely controllable disease. <h4>Methods:</h4> We performed a narrat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5b6fbbcd-3ddc-5c86-944e-03e43260c932
DOI
10.20944/preprints202604.0598.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Four Decades of Molecular Innovation in Chronic Myeloid Leukemia: From Antisense Targeting to Treatment-Free RemissionDOI 10.20944/preprints202604.0598.v1
Select a neighboring publication to make it the new centre.